Yuan P - Search Results

1

Down-regulation of hepatoma-derived growth factor inhibits anchorage-independent growth and invasion of non-small cell lung cancer cells.

Zhang J, Ren H, Yuan P, Lang W, Zhang L, Mao L. Zhang J, et al. Among authors: yuan p. Cancer Res. 2006 Jan 1;66(1):18-23. doi: 10.1158/0008-5472.CAN-04-3905. Cancer Res. 2006. PMID: 16397209

2

Overexpression of podoplanin in oral cancer and its association with poor clinical outcome.

Yuan P, Temam S, El-Naggar A, Zhou X, Liu DD, Lee JJ, Mao L. Yuan P, et al. Cancer. 2006 Aug 1;107(3):563-9. doi: 10.1002/cncr.22061. Cancer. 2006. PMID: 16804930 Free article.

3

Molecular basis of the synergistic antiangiogenic activity of bevacizumab and mithramycin A.

Jia Z, Zhang J, Wei D, Wang L, Yuan P, Le X, Li Q, Yao J, Xie K. Jia Z, et al. Among authors: yuan p. Cancer Res. 2007 May 15;67(10):4878-85. doi: 10.1158/0008-5472.CAN-06-3494. Cancer Res. 2007. PMID: 17510417

4

Inhibition of Stat3 activation and tumor growth suppression of non-small cell lung cancer by G-quartet oligonucleotides.

Weerasinghe P, Garcia GE, Zhu Q, Yuan P, Feng L, Mao L, Jing N. Weerasinghe P, et al. Among authors: yuan p. Int J Oncol. 2007 Jul;31(1):129-36. Int J Oncol. 2007. PMID: 17549413

5

Targeting signal transducer and activator of transcription 3 with G-quartet oligonucleotides: a potential novel therapy for head and neck cancer.

Jing N, Zhu Q, Yuan P, Li Y, Mao L, Tweardy DJ. Jing N, et al. Among authors: yuan p. Mol Cancer Ther. 2006 Feb;5(2):279-86. doi: 10.1158/1535-7163.MCT-05-0302. Mol Cancer Ther. 2006. PMID: 16505101

6

Therapeutic inhibition of Sp1 expression in growing tumors by mithramycin a correlates directly with potent antiangiogenic effects on human pancreatic cancer.

Yuan P, Wang L, Wei D, Zhang J, Jia Z, Li Q, Le X, Wang H, Yao J, Xie K. Yuan P, et al. Cancer. 2007 Dec 15;110(12):2682-90. doi: 10.1002/cncr.23092. Cancer. 2007. PMID: 17973266 Free article.

7

Prediction of survival in resected non-small cell lung cancer using a protein expression-based risk model: implications for personalized chemoprevention and therapy.

Gold KA, Kim ES, Liu DD, Yuan P, Behrens C, Solis LM, Kadara H, Rice DC, Wistuba II, Swisher SG, Hofstetter WL, Lee JJ, Hong WK. Gold KA, et al. Among authors: yuan p. Clin Cancer Res. 2014 Apr 1;20(7):1946-54. doi: 10.1158/1078-0432.CCR-13-1959. Epub 2013 Dec 23. Clin Cancer Res. 2014. PMID: 24366692 Free PMC article.

8

EZH2 protein expression associates with the early pathogenesis, tumor progression, and prognosis of non-small cell lung carcinoma.

Behrens C, Solis LM, Lin H, Yuan P, Tang X, Kadara H, Riquelme E, Galindo H, Moran CA, Kalhor N, Swisher SG, Simon GR, Stewart DJ, Lee JJ, Wistuba II. Behrens C, et al. Among authors: yuan p. Clin Cancer Res. 2013 Dec 1;19(23):6556-65. doi: 10.1158/1078-0432.CCR-12-3946. Epub 2013 Oct 4. Clin Cancer Res. 2013. PMID: 24097870 Free PMC article.

9

A five-gene and corresponding protein signature for stage-I lung adenocarcinoma prognosis.

Kadara H, Behrens C, Yuan P, Solis L, Liu D, Gu X, Minna JD, Lee JJ, Kim E, Hong WK, Wistuba II, Lotan R. Kadara H, et al. Among authors: yuan p. Clin Cancer Res. 2011 Mar 15;17(6):1490-501. doi: 10.1158/1078-0432.CCR-10-2703. Epub 2010 Dec 16. Clin Cancer Res. 2011. PMID: 21163870 Free PMC article.

10

Network Pharmacology and Transcriptomics Reveal the Mechanism of GuaLouQuMaiWan in Treatment of Type 2 Diabetes and Its Active Small Molecular Compound.

Feng J, Zhou Y, Liao L, Yu L, Yuan P, Zhang J. Feng J, et al. Among authors: yuan p. J Diabetes Res. 2022 Oct 6;2022:2736504. doi: 10.1155/2022/2736504. eCollection 2022. J Diabetes Res. 2022. PMID: 36248223 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,653 results

Search Page

Filters